Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
- PMID: 9435691
- DOI: 10.1152/ajprenal.1997.273.6.F1013
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
Abstract
Peroxisome proliferator-activated receptors (PPARs, alpha, beta/delta, and gamma) are members of the nuclear receptor superfamily of ligand-activated transcription factors. PPARs regulate the expression of genes involved in lipid metabolism. 8(S)-hydroxyeicosatetraenoic acid (8-S-HETE), leukotriene B4 (LTB4), and hypolipidemic fibrates activate PPAR alpha, whereas PPAR gamma is activated by prostaglandin metabolites. The present studies examined the intrarenal and tissue distribution of rabbit and human PPAR alpha, -beta/delta, and -gamma mRNAs. Nuclease protection showed PPAR alpha predominated in liver, heart, and kidney, whereas PPAR gamma, a putative adipose-specific transcription factor, was in white adipose tissue, bladder, and ileum, followed by kidney and spleen. Lower expression levels of PPAR beta/delta were observed in several tissues. In situ hybridization of kidney showed PPAR alpha mRNA predominated in proximal tubules and medullary thick ascending limbs of both rabbit and human. PPAR gamma was exclusively expressed in medullary collecting duct and papillary urothelium. Immunoblot confirmed the expression of PPAR gamma protein in freshly isolated inner medullary collecting ducts. mRNAs for all the PPARs were expressed in the ureter and bladder in both rabbit and human, but PPAR gamma expression was greatest. This distinct distribution of PPAR isoforms has important implications for lipid-activated gene transcription in urinary epithelia.
Similar articles
-
Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.Minerva Urol Nefrol. 2002 Jun;54(2):65-79. Minerva Urol Nefrol. 2002. PMID: 12185990 Review.
-
Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney.Am J Physiol. 1999 Dec;277(6):F966-73. doi: 10.1152/ajprenal.1999.277.6.F966. Am J Physiol. 1999. PMID: 10600944
-
Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.Mol Pharmacol. 1996 Jul;50(1):67-74. Mol Pharmacol. 1996. PMID: 8700121
-
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.Kidney Int. 2001 Jul;60(1):14-30. doi: 10.1046/j.1523-1755.2001.00766.x. Kidney Int. 2001. PMID: 11422732 Review.
-
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.J Clin Invest. 1996 Jun 1;97(11):2553-61. doi: 10.1172/JCI118703. J Clin Invest. 1996. PMID: 8647948 Free PMC article.
Cited by
-
The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.Curr Diab Rep. 2013 Jun;13(3):329-41. doi: 10.1007/s11892-013-0378-8. Curr Diab Rep. 2013. PMID: 23625197 Review.
-
Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.Am J Physiol Renal Physiol. 2012 Mar 1;302(5):F540-51. doi: 10.1152/ajprenal.00306.2011. Epub 2011 Dec 14. Am J Physiol Renal Physiol. 2012. PMID: 22169011 Free PMC article.
-
PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel.Pflugers Arch. 2005 Dec;451(3):445-53. doi: 10.1007/s00424-005-1477-4. Epub 2005 Sep 17. Pflugers Arch. 2005. PMID: 16170524
-
Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.J Membr Biol. 2010 Aug;236(3):259-70. doi: 10.1007/s00232-010-9297-7. Epub 2010 Aug 26. J Membr Biol. 2010. PMID: 20740360
-
Pioglitazone and bladder cancer risk: a systematic review and meta-analysis.Cancer Med. 2018 Apr;7(4):1070-1080. doi: 10.1002/cam4.1354. Epub 2018 Feb 24. Cancer Med. 2018. PMID: 29476615 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources